PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2016 | 22 |
| 2017 | 38 |
| 2018 | 33 |
| 2019 | 64 |
| 2020 | 299 |
| 2021 | 439 |
| 2022 | 400 |
| 2023 | 466 |
| 2024 | 371 |
| 2025 | 428 |
| 2026 | 479 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Signal Transduct Target Ther"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Arrhythmic events and genetic variants as drivers for Takotsubo Syndrome: a patient-specific atrial stem-cell model.
- Brand C, Zinke C, Syed Ali G, Hübscher D, Ajmail K, Seedorf A, Steinker P, Treu F, Jung P, Eberl H, Li Y, Dybkova N, Feld L, Ghadri JR, Templin C, Sossalla S, Maack C, Voigt N, Nikolaev VO, Wollnik B, Streckfuss-Bömeke K.
- Signal Transduct Target Ther. 2026 Oct 23;11(1):463. doi: 10.1038/s41392-026-03000-z.
- PMCID: PMC13691113
Brand C, et al.Signal Transduct Target Ther. 2026.PMCID: PMC13691113 -
Nicotinic acid starvation sensitizes nicotinate phosphoribosyltransferase-expressing tumors to nicotinamide phosphoribosyltransferase inhibition.
- Ghanem MS, Ravera S, Benelli R, Nahimana A, Piacente F, Caffa I, Nencioni A.
- Signal Transduct Target Ther. 2026 Oct 22;11(1):462. doi: 10.1038/s41392-026-03007-6.
- PMCID: PMC13687021
Ghanem MS, et al.Signal Transduct Target Ther. 2026.PMCID: PMC13687021 -
An iron compass in the liver: superparamagnetic macrophages give homing pigeons a magnetic sense.
- Liu Y, Fang J, Sankowski R.
- Signal Transduct Target Ther. 2026 Oct 21;11(1):461. doi: 10.1038/s41392-026-03004-9.
- PMCID: PMC13683387
Liu Y, et al.Signal Transduct Target Ther. 2026.PMCID: PMC13683387 -
Nanotherapeutic macrophage reprogramming through immunometabolic and microbial modulation for sepsis treatment.
- Lu X, Wang W, Zhang B, Li Q, Chen Y, Hai Y, Fan R, Fu S, Yan J, Ding G, Hou Z, Song J, Cheng M, Wei G.
- Signal Transduct Target Ther. 2026 Oct 21;11(1):467. doi: 10.1038/s41392-026-02947-3.
- PMCID: PMC13683383
Lu X, et al.Signal Transduct Target Ther. 2026.PMCID: PMC13683383 -
From cryptic exons to neuronal dysfunction: combinatorial antisense makes sense in TAR DNA-binding protein-43 (TDP-43) pathology.
- Figlia G, Bremer J.
- Signal Transduct Target Ther. 2026 Oct 21;11(1):460. doi: 10.1038/s41392-026-03002-x.
- PMCID: PMC13683332
Figlia G, et al.Signal Transduct Target Ther. 2026.PMCID: PMC13683332 -
Mitophagy coordinates organelle crosstalk in health and diseases.
- Wu M, He P, Lian Y, Zhang T, Wu Y, Wang L, Tang D, Yao Y, Yao R.
- Signal Transduct Target Ther. 2026 Oct 20;11(1):458. doi: 10.1038/s41392-026-02812-3.
- PMCID: PMC13680487
Wu M, et al.Signal Transduct Target Ther. 2026.PMCID: PMC13680487 -
Entinostat plus exemestane for hormone receptor-positive advanced breast cancer: long-term overall survival results from the EOC103A3101 randomized controlled trial.
- Wang J, Zhang Q, Hu X, Sun T, Li W, Ouyang Q, Wang J, Tong Z, Yan M, Li H, Zeng X, Shan C, Wang X, Zhang J, Zhang Y, Zhang L, Shang H, Xu B.
- Signal Transduct Target Ther. 2026 Oct 20;11(1):457. doi: 10.1038/s41392-026-02899-8.
- PMCID: PMC13680365
Wang J, et al.Signal Transduct Target Ther. 2026.PMCID: PMC13680365 -
Real-world renoprotective effects of polyethylene glycol-loxenatide in type 2 diabetes: a multicenter, ambispective cohort study.
- Ye J, Li J, Chen Y, Chen F, Zhu D, Zhang C, Chen Q, Tian Y, Yang S, Xu W, Xie B, Chen ZS, Hou K.
- Signal Transduct Target Ther. 2026 Oct 20;11(1):456. doi: 10.1038/s41392-026-02945-5.
- PMCID: PMC13680378
Ye J, et al.Signal Transduct Target Ther. 2026.PMCID: PMC13680378 -
Matrix metalloproteinase-guided targeting of vesicular stomatitis virus to tumors following systemic administration.
- Theune EV, Theune WC, Ahmadi E, Chiari CC, Singh N, Geyer R, Tonne J, Metko M, Olaoba OT, Wang IC, Dai D, Ruan J, Clark R, Li G, Wang P, Jellison ER, Vella AT, Vile R, Wang K.
- Signal Transduct Target Ther. 2026 Oct 20;11(1):455. doi: 10.1038/s41392-026-02888-x.
- PMCID: PMC13680497
Theune EV, et al.Signal Transduct Target Ther. 2026.PMCID: PMC13680497 -
Cytokine context shapes antigen-presenting and matrix-producing states of cancer-associated fibroblasts.
- Song F, Chen Q, Huang D, Zhang Y, Han D, Rao W, Li M, Gao Y, Zhang R, Zhu H, Wang S, Jiang X, Lin S, Bi D, Zhang H, Wei Q, Qin H.
- Signal Transduct Target Ther. 2026 Oct 20;11(1):459. doi: 10.1038/s41392-026-02965-1.
- PMCID: PMC13680625
Song F, et al.Signal Transduct Target Ther. 2026.PMCID: PMC13680625